Federal grants to Optimeos Life Sciences, Inc.
Optimeos Life Sciences, Inc. in Princeton, New Jersey received $2.9 million in federal grants from fiscal 2021 to 2025, across 6 awards. Its largest program was Technology, Innovation, and Partnerships, with $1.5 million. In fiscal 2025 it was awarded $800,000.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$2.9 million
- Awards6
- Awarded in FY 2025$800,000
- Largest award$1.5 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $511,351 |
| FY 2022 | 1 | $287,726 |
| FY 2023 | 1 | $1.0 million |
| FY 2024 | 1 | $300,000 |
| FY 2025 | 2 | $800,000 |
Programs that fund Optimeos Life Sciences, Inc.
| Program | Awards | Amount |
|---|---|---|
| Technology, Innovation, and Partnerships | 1 | $1.5 million |
| Allergy and Infectious Diseases Research | 2 | $600,000 |
| National Center for Advancing Translational Sciences | 1 | $287,726 |
| Engineering | 1 | $256,000 |
| Biomedical Research and Research Training | 1 | $255,351 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| National Science Foundation | 2 | $1.8 million |
| Department of Health and Human Services | 4 | $1.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Sbir phase II: formulation of a mrna-based therapy for CTLN1 by inverse flash nanoprecipitation -the broader impact/commercial potential of this small business innovation research (SBIR) phase II project will be to enhance american and global healthcare through new technologies enabling clinical tra | Technology, Innovation, and Partnerships | July 5, 2023 | $1.5 million |
| In vivo targeted delivery of nucleic acids to hematopoietic stem cells for treating primary immunodeficiencies - summary in this phase i sbir, optimeos will develop an off-the-shelf nanoparticle platform for in vivo stem cell gene therapy, which we will initially apply to treat ada-scid, a severe im | Allergy and Infectious Diseases Research | August 19, 2025 | $300,000 |
| Targeted delivery of nucleic acid formulations for in vivo car-treg generation - in this phase i sbir, optimeos will develop an off-the-shelf, in situ car-treg therapy through the nanoparticle-mediated delivery of a CAR-FOXP3 construct to CD4+ t cells as a treatment for transplant rejection. We envi | Allergy and Infectious Diseases Research | April 9, 2024 | $300,000 |
| Highly loaded long-acting depots of therapeutic peptides - peptides can have exquisite potency and selectivity in treating disease, but suffer from rapid clearance. Microparticle depot formulations, where the peptide is entrapped in a water-insoluble polymer matrix, have been tested for decades to p | National Center for Advancing Translational Sciences | May 18, 2022 | $287,726 |
| Sttr phase i: formulation of a COVID-19 mrna vaccine by inverse flash nanoprecipitation | Engineering | January 5, 2021 | $256,000 |
| Sustained release formulations of therapeutic antibodies - this application seeks to develop a long-acting depot formulation for antibodies, using the inverse flash nanoprecipitation (IFNP) platform being commercialized by optimeos life sciences. Microparticle depot formulations have been tested for | Biomedical Research and Research Training | September 2, 2021 | $255,351 |
Questions people ask
How much federal grant money does Optimeos Life Sciences, Inc. get?
$2.9 million in 6 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Optimeos Life Sciences, Inc. the most?
The National Science Foundation, with $1.8 million in 2 awards. The Department of Health and Human Services follow.
What is Optimeos Life Sciences, Inc.'s largest federal grant?
$1.5 million under Technology, Innovation, and Partnerships, with its first action in the period on July 5, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Optimeos Life Sciences, Inc.?
Its largest are Technology, Innovation, and Partnerships, Allergy and Infectious Diseases Research and National Center for Advancing Translational Sciences.
Other grant recipients in Princeton
- The Trustees of Princeton University
- Institute for Advanced Study - Louis Bamberger & MRS Felix Fuld Foundation
- Educational Testing Service
- Center for Supportive Schools, Inc.
- Siemens Corporation
- Foundation of the University of the Valley of Guatemala
- Treadstone Technologies, Inc.
- Documentation Center of Cambodia Inc
Largest federal grant recipients in New Jersey · Federal grants in New Jersey